Ana səhifə

Рекомендації щодо ведення хворих з ішемічним інсультом та транзиторною ішемічною атакою


Yüklə 1.09 Mb.
səhifə11/11
tarix25.06.2016
ölçüsü1.09 Mb.
1   2   3   4   5   6   7   8   9   10   11

  • Fiehler J, Albers G, JM B, Derex L, Gass A, Hjort N, Kim J, Liebeskind D, Neumann-Haefelin T, Pedraza S, Rother J, Rothwell P, Rovira A, Schellinger P, Trenkler J, Group. ftMS: Bleeding risk analysis in stroke imaging before thrombolysis (brasil). Pooled analysis of t2*-weighted magnetic resonance imaging data from 570 patients. Stroke 2007;38:2738-2744.

  • Forsting M, Wanke I: Funeral for a friend. Stroke 2003;34:1324-1332.

  • Willinsky R, Taylor S, TerBrugge K, Farb R, Tomlinson G, Montanera W: Neurologic complications of cerebral angiography: Prospective analysis of 2,899 procedures and review of the literature. Radiology 2003;227:522-528.

    170 *** Wardlaw J, Chappell F, Best J, Wartolowska K, Berry E, on behalf of the NHS R & D Health Technology Assessment Carotid Stenosis Imaging Group: Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: A meta-analysis. Lancet 2006;367:1503-1512.

    1. Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G, Gough M, Brennan A, Bamford J, Best J: Accurate, practical and cost-effective assessment of carotid stenosis in the uk. Health Technol Assess 2006;10:iii-iv, ix-x, 1-182.

    2. Flossmann E, Rothwell P: Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. Brain 2003;126:1940-1954.

    3. Khan S, Cloud GC, Kerry S, Markus HS: Imaging of vertebral artery stenosis: A systematic review. J Neurol Neurosurg Psychiatry 2007;78:1218-1225.

    4. Postert T, Federlein J, Przuntek H, Buttner T: Insufficient and absent acoustic temporal bone window: Potential and limitations of transcranial contrast-enhanced color-coded sonography and contrast-enhanced power-based sonography. Ultrasound Med Biol 1997;23:857-862.

    5. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC: Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: Sonographic classification and short-term improvement. Circulation 2001;103:2897-2902.

    6. Droste D, Jurgens R, Nabavi D, Schuierer G, Weber S, Ringelstein E: Echocontrast-enhanced ultrasound of extracranial internal carotid artery high-grade stenosis and occlusion. Stroke 1999;30:2302-2306.

    7. Droste D, Jurgens R, Weber S, Tietje R, Ringelstein E: Benefit of echocontrast-enhanced transcranial color-coded duplex ultrasound in the assessment of intracranial collateral pathways. Stroke 2000;31:920-923.

    8. Droste D, Nabavi D, Kemeny V, Schulte-Altedorneburg G, Ritter M, Weber S, Ringelstein E: Echocontrast enhanced transcranial colour-coded duplex offers improved visualization of the vertebrobasilar system. Acta Neurol Scand 1998;98:198-199.

    9. Ringelstein E, Van Eyck S, Mertens I: Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: Comparison of co2 to acetazolamide. Cereb Blood Flow Metab 1992;12:162-168.

    180 *** Nederkoorn P, van der Graaf Y, Hunink M: Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: A systematic review. Stroke 2003;34:1324-1332.

    1. Markus H, Cullinane M: Severely impaired cerebrovascular reactivity predicts stroke and tia risk in patients with carotid artery stenosis and occlusion. Brain 2001;124:457-467.

    2. Blaser T, Hofmann K, Buerger T, Effenberger O, Wallesch C, Goertler M: Risk of stroke, transient ischemic attack, and vessel occlusion before endarteriectomy in patients with symptomatic severe carotid stenosis. Stroke 2002;33:1057-1062.

    1. Ringelstein E, Droste D, Babikian V, Evans D, Grosset D, Kaps M, Markus H, Russell D, Siebler M: International consensus group on microembolus detection. Consensus on microembolus detection by tcd. Stroke 1998;29:725-729.

    2. Markus H, MacKinnon A: Asymptomatic embolisation, detected by doppler ultrasound, predicts stroke risk in symptomatic carotid artery stenosis. Stroke 2005;36:971-975.

    3. Markus H, Droste D, Kaps M, Larrue V, Lees K, Siebler M, Ringelstein E: Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection; the caress trial. Circulation 2005;111:2233-2240.

    4. Klötzsch C, Janssen G, Berlit P: Transesophageal echocardiography and contrast-tcd in the detection of a patent foramen ovale: Experiences with 111 patients. Neurology 1994;44:1603-1606.

    5. Rothwell P, Buchan A, Johnston S: Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2005;5:323-331.

    6. Daffertshofer M, Mielke O, Pullwitt A, Felsenstein M, Hennerici M: Transient ischemic attacks are more than "ministrokes". Stroke 2004;35:2453-2458.

    7. Crisostomo R, Garcia M, Tong D: Detection of diffusion-weighted mri abnormalities in patients with transient ischemic attack: Correlation with clinical characteristics. Stroke 2003;34:932-937.

    8. Coutts S, Simon J, Eliasziw M, Sohn C, Hill M, Barber P, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott J, Buchan A, Demchuk A: Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005;57:848-854.

    9. Redgrave J, Coutts S, Schulz U, Briley D, Rothwell P: Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 2007;38:1482-1488.

    10. Douglas V, Johnston C, Elkins J, Sidney S, Gress D, Johnston GS: Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke 2003;34:2894-2898.

    11. Christensen H, Fogh Christensen A, Boysen GG: Abnormalities on ecg and telemetry predict stroke outcome at 3 months. J Neurol Sci 2005;234:99 –103.

    12. Fure B, Bruun Wyller T, Thommessen B: Electrocardiographic and troponin t changes in acute ischaemic stroke. J Intern Med 2006;259:592-597.

    13. Tatschl C, Stollberger C, Matz K, Yilmaz N, Eckhardt R, Nowotny M, Dachenhausen A, Brainin M: Insular involvement is associated with qt prolongation: Ecg abnormalities in patients with acute stroke. Cerebrovasc Dis 2006;21:47-53.

    14. Gunalp M, Atalar E, Coskun F, Yilmaz A, Aksoyek S, Aksu NM, Sivri B: Holter monitoring for 24 hours in patients with thromboembolic stroke and sinus rhythm diagnosed in the emergency department. Adv Ther 2006;23:854-860.

    15. Douen AG, Pageau N, Medic S: Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke 2008;39:480-482.

    16. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M: Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: A systematic review. Stroke 2007;38:2935-2940.

    17. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R: Usefulness of ambulatory 7-day ecg monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004;35:1647-1651.

    18. Lerakis S, Nicholson WJ: Part i: Use of echocardiography in the evaluation of patients with suspected cardioembolic stroke. Am J Med Sci 2005;329:310-316.

    1. Kapral MK, Silver FL: Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian task force on preventive health care. Cmaj 1999;161:989-996.

    2. de Bruijn SF, Agema WR, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER, Bollen EL, Bax JJ: Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke 2006;37:2531-2534.

    3. Chiarella F, Santoro E, Domenicucci S, Maggioni A, Vecchio C: Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the gissi-3 study. Am J Cardiol 1998;81:822-827.

    4. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG: Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation iii investigators. J Am Coll Cardiol 1998;31:1622-1626.

    5. Kurth T, Moore S, Gaziano J, Kase C, Stampfer M, Berger K, Buring J: Healthy lifestyle and the risk of stroke in women. Arch Intern Med 2006;166:1403-1409.

    6. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.

    7. Neal B, MacMahon S, Chapman N: Effects of ace inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Blood pressure lowering treatment trialists' collaboration. Lancet 2000;356:1955-1964.

    8. Staessen J, Fagard R, Thijs L, Celis H, Arabidze G, Birkenhager W, Bulpitt C, de Leeuw P, Dollery C, Fletcher A, Forette F, Leonetti G, Nachev C, O'Brien E, Rosenfeld J, Rodicio J, Tuomilehto J, Zanchetti A: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in europe (Syst-Eur) trial investigators. Lancet 1997;350:757-764.

    9. Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, Casiglia E, Kerlikowske K, Coope J: Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials. Indana group. Lancet 1999;353:793-796.




    1. *** Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Struijker-Boudier HA, Viigimaa M, Adamopoulos S, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, O'Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B, The task force for the management of arterial hypertension of the European Society of H, The task force for the management of arterial hypertension of the European Society of C: 2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension (esh) and of the european society of cardiology (esc). Eur Heart J 2007;28:1462-1536.

    2. *** Mancia G: Optimal control of blood pressure in patients with diabetes reduces the incidence of macro- and microvascular events. J Hypertens Suppl 2007;25 Suppl 1:S7-12.




    1. Black H, Elliott W, Grandits G, Grambsch P, Lucente T, White W, Neaton J, Grimm R, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber M, Williams G, Wittes J, Zanchetti A, Anders R: Principal results of the controlled onset verapamil investigation of cardiovascular end points (convince) trial. JAMA 2003;289:2073-2082.

    2. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H: Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (life): A randomised trial against atenolol. Lancet 2002;359:995-1003.

    1. Kizer J, Dahlof B, Kjeldsen S, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm L, Nieminen M, Omvik P, Oparil S, Wedel H, Wachtell K, Edelman J, Snapinn S, Harris K, Devereux R: Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: The losartan intervention for endpoint reduction in hypertension study. Hypertension 2005;45:46-52.

    2. ALLHAT investigators: Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhat-llt). JAMA 2002;288:2998-3007.

    3. Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlof B, Schersten B: Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in stop-hypertension-2. Blood Press 2004;13:137-141.

    4. Turner RC, Cull CA, Frighi V, Holman RR: Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (ukpds 49). Uk prospective diabetes study (ukpds) group. JAMA 1999;281:2005-2012.

    5. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (cards): Multicentre randomised placebo-controlled trial. Lancet 2004;364:685-696.

    6. Sever PS, Poulter NR, Dahlof B, Wedel H, Collins R, Beevers G, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J: Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-scandinavian cardiac outcomes trial--lipid-lowering arm (ascot-lla). Diabetes Care 2005;28:1151-1157.




    1. *** Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C: Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. Lancet 2008;371:117-125.

    2. *** Amarenco P, Labreuche J, Lavallee P, Touboul P: Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-2909.




    1. Heart Protection Study Collaborative Group: Mrc/bhf heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7-22.

    2. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ: Cigarette smoking as a risk factor for stroke. The framingham study. JAMA 1988;259:1025-1029.

    3. Abbott RD, Yin Y, Reed DM, Yano K: Risk of stroke in male cigarette smokers. N Engl J Med 1986;315:717-720.

    4. Colditz GA, Bonita R, Stampfer MJ, Willett WC, Rosner B, Speizer FE, Hennekens CH: Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med 1988;318:937-941.

    5. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH: Smoking cessation and decreased risk of stroke in women. JAMA 1993;269:232-236.

    6. Wannamethee SG, Shaper AG, Whincup PH, Walker M: Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995;274:155-160.

    7. Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, Koizumi A, Wada Y, Kondo T, Inaba Y, Tamakoshi A: Smoking cessation and mortality from cardiovascular disease among japanese men and women: The jacc study. Am J Epidemiol 2005;161:170-179.

    8. Qureshi A, Suri M, Kirmani J, Divani A: Cigarette smoking among spouses: Another risk factor for stroke in women. Stroke 2005;36:74-76.

    1. Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;298:789-794.

    2. Ong M, Glantz S: Cardiovascular health and economic effects of smoke-free workplaces. Am J Med 2004;117:32-38.

    3. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J: Alcohol consumption and risk of stroke: A meta-analysis. JAMA 2003;289:579-588.

    4. Mukamal K, Ascherio A, Mittleman M, Conigrave K, Camargo C, Kawachi I, Stampfer M, Willett W, Rimm E: Alcohol and risk for ischemic stroke in men: The role of drinking patterns and usual beverage. Ann Intern Med 2005;142:11-19.

    5. Bazzano LA, Gu D, Reynolds K, Wu X, Chen CS, Duan X, Chen J, Wildman RP, Klag MJ, He J: Alcohol consumption and risk for stroke among chinese men. Ann Neurol 2007;62:569-578.

    6. Lee C, Folsom A, Blair S: Physical activity and stroke risk: A meta-analysis. Stroke 2003;34:2475-2481.

    7. Deplanque D, Masse I, Lefebvre C, Libersa C, Leys D, Bordet R: Prior tia, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006;67:1403-1410.

    8. Joshipura KJ, Ascherio A, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Hennekens CH, Spiegelman D, Willett WC: Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999;282:1233-1239.

    9. He K, Song Y, Daviglus M, Liu K, Van Horn L, Dyer A, Goldbourt U, Greenland P: Fish consumption and incidence of stroke: A meta-analysis of cohort studies. Stroke 2004;35:1538-1542.

    10. Mellen PB, Walsh TF, Herrington DM: Whole grain intake and cardiovascular disease: A meta-analysis. Nutr Metab Cardiovasc Dis 2007;85:1495-1502.

    11. Umesawa M, Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, Koizumi A, Kondo T, Inaba Y, Tanabe N, Tamakoshi A: Dietary intake of calcium in relation to mortality from cardiovascular disease: The jacc study. Stroke 2006;37:20-26.

    12. He K, Merchant A, Rimm E, Rosner B, Stampfer M, Willett W, Ascherio A: Dietary fat intake and risk of stroke in male us healthcare professionals: 14 year prospective cohort study. BMJ 2003;327:777-782.

    13. Howard B, Van Horn L, Hsia J, Manson J, Stefanick M, Wassertheil-Smoller S, Kuller L, LaCroix A, Langer R, Lasser N, Lewis C, Limacher M, Margolis K, Mysiw W, Ockene J, Parker L, Perri M, Phillips L, Prentice R, Robbins J, Rossouw J, Sarto G, Schatz I, Snetselaar L, Stevens V, Tinker L, Trevisan M, Vitolins M, Anderson G, Assaf A, Bassford T, Beresford S, Black H, Brunner R, Brzyski R, Caan B, Chlebowski R, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix S, Hubbell F, Johnson K, Kotchen J: Low-fat dietary pattern and risk of cardiovascular disease: The women's health initiative randomized controlled dietary modification trial. JAMA 2006;295:655-666.

    14. Kurth T, Gaziano J, Berger K, Kase C, Rexrode K, Cook N, Buring J, Manson J: Body mass index and the risk of stroke in men. Arch Intern Med 2002;162:2557-2562.

    15. Kurth T, Gaziano J, Rexrode K, Kase C, Cook N, Manson J, Buring J: Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005;111:1992-1998.

    16. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Mannisto S, Jousilahti P: Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 2007;167:1420-1427.

    17. Neter J, Stam B, Kok F, Grobbee D, Geleijnse J: Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2003;42:878-884.

    18. Curioni C, Andre C, Veras R: Weight reduction for primary prevention of stroke in adults with overweight or obesity. Cochrane Database Syst Rev 2006;CD006062

    1. Marniemi J, Alanen E, Impivaara O, Seppanen R, Hakala P, Rajala T, Ronnemaa T: Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005;15:188-197.

    2. Hsia J, Heiss G, Ren H, Allison M, Dolan N, Greenland P, Heckbert S, Johnson K, Manson J, Sidney S, Trevisan M: Calcium/vitamin d supplementation and cardiovascular events. Circulation 2007;115:846-854.

    3. Tornwall M, Virtamo J, Korhonen P, Virtanen M, Albanes D, Huttunen J: Postintervention effect of alpha tocopherol and beta carotene on different strokes: A 6-year follow-up of the alpha tocopherol, beta carotene cancer prevention study. Stroke 2004;35:1908-1913.

    4. *** Miller E, Pastor-Barriuso R, Dalal D, Riemersma R, Appel L, Guallar E: Meta-analysis:

    5. High-dosage vitamin e supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.

    1. The Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002;288:2015-2022.

    2. Yang Q, Botto LD, Erickson JD, Berry RJ, Sambell C, Johansen H, Friedman JM: Improvement in stroke mortality in canada and the united states, 1990 to 2002. Circulation 2006;113:1335-1343.

    3. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X: Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 2007;369:1876-1882.

    4. Grodstein F, Manson JE, Stampfer MJ: Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. A prospective, observational study. Ann Intern Med 2001;135:1-8.

    5. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N: Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (hers ii). JAMA 2002;288:49-57.

    257 *** Gabriel S, Carmona L, Roque M, Sanchez G, Bonfill X: Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2005:CD002229.

    1. Brunner R, Gass M, Aragaki A, Hays J, Granek I, Woods N, Mason E, Brzyski R, Ockene J, Assaf A, LaCroix A, Matthews K, Wallace R: Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: Results from the women's health initiative randomized clinical trial. Arch Intern Med 2005;165:1976-1986.

    2. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477.

    3. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S: Randomised trial of prophylactic daily aspirin in british male doctors. Br Med J (Clin Res Ed) 1988;296:313-316.

    4. Steering Committee of the Physicians' Health Study Research Group: Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989;321:129-135.

    5. ETDRS Investigators: Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 14. JAMA 1992;268:1292-1300.

    6. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (hot) randomised trial. Hot study group. Lancet 1998;351:1755-1762.

    7. de Gaetano G: Low-dose aspirin and vitamin e in people at cardiovascular risk: A randomised trial in general practice. Collaborative group of the primary prevention project. Lancet 2001;357:89-95.

    1. Iso H, Hennekens C, Stampfer M, Rexrode K, Colditz G, Speizer F, Willett W, Manson J: Prospective study of aspirin use and risk of stroke in women. Stroke 1999;30:1764-1771.

    2. Bartolucci A, Howard G: Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin. Am J Cardiol 2006;98:746-750.

    267 *** Berger J, Roncaglioni M, Avanzini F, Pangrazzi I, Tognoni G, Brown D: Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306-313.

    268 Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE: A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-1304.

    269 *** Bhatt D, Fox K, Hacke W, Berger P, Black H, Boden W, Cacoub P, Cohen E, Creager M, Easton J, Flather M, Haffner S, Hamm C, Hankey G, Johnston S, Mak K, Mas J, Montalescot G, Pearson T, Steg P, Steinhubl S, Weber M, Brennan D, Fabry-Ribaudo L, Booth J, Topol E: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-1717.


    1. Hobson R, 2nd, Krupski W, Weiss D: Influence of aspirin in the management of asymptomatic carotid artery stenosis. Va cooperative study group on asymptomatic carotid stenosis. J Vasc Surg 1993;17:257-263.

    2. Engelter S, Lyrer P: Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy. Cochrane Database Syst Rev 2003:CD001458.




    1. *** Hart RG, Pearce LA, Aguilar MI: Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-867.

    2. *** Rash A, Downes T, Portner R, Yeo W, Morgan N, Channer K: A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (waspo). Age Ageing 2007;36:151-156.




    1. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E: Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the birmingham atrial fibrillation treatment of the aged study, bafta): A randomised controlled trial. Lancet 2007;370:493-503.

    2. Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S: Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (active w): A randomised controlled trial. Lancet 2006;367:1903-1912.

    3. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E: Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-17.

    277 *** Chambers BR, Donnan GA: Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005:CD001923.

    278 Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428.



    1. *** Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004;363:1491-1502.

    2. *** North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. New England Journal of Medicine 1991;325:445-453.

    281 Baker WH, Howard VJ, Howard G, Toole JF: Effect of contralateral occlusion on long-term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (acas). Acas investigators. Stroke 2000;31:2330-2334.

    1. Straus SE, Majumdar SR, McAlister FA: New evidence for stroke prevention: Scientific review. JAMA 2002;288:1388-1395.

    2. The European Carotid Surgery Trialists Collaborative Group: Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209-212.

    3. Mayo Asymptomatic Carotid Endarterectomy Study Group: Results of a randomized controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo asymptomatic carotid endarterectomy study group. Mayo Clin Proc 1992;67:513-518.

    4. Derdeyn C: Carotid stenting for asymptomatic carotid stenosis: Trial it. Stroke 2007;38:715-720.

    5. Rashid P, Leonardi-Bee J, Bath P: Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review. Stroke 2003;34:2741-2748.

    6. Group P: Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl) 1995;108:710–717.

    7. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 2000;342:145-153.

    8. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, Davies R, Ostergren J, Probstfield J: Use of ramipril in preventing stroke: Double blind randomised trial. BMJ 2002;324:699-702.

    9. PROGRESS collaborative group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.

    10. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, Jones D, Materson B, Oparil S, Wright J, Roccella E: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The jnc 7 report. JAMA 2003;289:2560-2572.

    11. Schrader J, Luders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener H: Morbidity and mortality after stroke: Eprosartan compared with nitrendipine for secondary prevention: Principal results of a prospective randomized controlled study (moses). Stroke 2005;36:1218-1226.

    12. Wilcox R, Bousser MG, Betteridge DJ, Schernthaner G, Pirags V, Kupfer S, Dormandy J: Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: Results from proactive (prospective pioglitazone clinical trial in macrovascular events 04). Stroke 2007;38:865-873.




    1. *** Amarenco P, Bogousslavsky J, Callahan A, Goldstein L, Hennerici M, Rudolph A, Sillesen H, Simunovic L, Szarek M, Welch K, Zivin J: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.

    2. *** Blanco M, Nombela F, Castellanos M, Rodriguez-Yanez M, Garcia-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Davalos A, Castillo J: Statin treatment withdrawal in ischemic stroke: A controlled randomized study. Neurology 2007;69:904-910.




    1. Vivekananthan D, Penn M, Sapp S, Hsu A, Topol E: Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials. Lancet 2003;361:2017-2023.

    2. Eidelman R, Hollar D, Hebert P, Lamas G, Hennekens C: Randomized trials of vitamin e in the treatment and prevention of cardiovascular disease. Arch Intern Med 2004;164:1552-1556.

    298 *** Bjelakovic G, Nikolova D, Gluud L, Simonetti R, Gluud C: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta- analysis. JAMA 2007;297:842-857.

    1. Wald D, Law M, Morris J: Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 2002;325:1202.

    2. Toole J, Malinow M, Chambless L, Spence J, Pettigrew L, Howard V, Sides E, Wang C, Stampfer M: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (visp) randomized controlled trial. JAMA 2004;291:565-575.

    3. Bonaa K, Njolstad I, Ueland P, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug J, Arnesen E, Rasmussen K: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-1588.

    4. Bazzano L, Reynolds K, Holder K, He J: Effect of folic acid supplementation on risk of cardiovascular diseases: A meta-analysis of randomized controlled trials. JAMA 2006;296:2720-2726.

    5. VITATOPS Trial Study Group: The vitatops (vitamins to prevent stroke) trial: Rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovasc Dis 2002;13:120-126.

    304 *** Bassetti CL: Sleep and stroke. Semin Neurol 2005;25:19-32.

    1. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A: Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007;357:2262-2268.

    2. Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000;55:1172-1179.

    3. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S: Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007;49:797-802.

    4. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, Whisnant JP, Wiebers DO, Covalt JL, Petterson TM, Christianson TJ, Agmon Y: Patent foramen ovale: Innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006;47:440-445.

    5. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.

    6. Wahl A, Krumsdorf U, Meier B, Sievert H, Ostermayer S, Billinger K, Schwerzmann M, Becker U, Seiler C, Arnold M, Mattle HP, Windecker S: Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005;45:377-380.

    7. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B: Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758.




    1. *** Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI: A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001;345:1243-1249.

    2. *** Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.




    1. Algra A, van Gijn J: Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 1996;60:197-199.

    2. The Dutch TIA Trial Study Group: A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991;325:1261-1266.

    3. Farrell B, Godwin J, Richards S, Warlow C: The united kingdom transient ischaemic attack (uk-tia) aspirin trial: Final results. J Neurol Neurosurg Psychiatry 1991;54:1044-1054.

    4. Campbell C, Smyth S, Montalescot G, Steinhubl S: Aspirin dose for the prevention of cardiovascular disease: A systematic review. JAMA 2007;297:2018-2024.

    1. *** Chimowitz M, Lynn M, Howlett-Smith H, Stern B, Hertzberg V, Frankel M, Levine S, Chaturvedi S, Kasner S, Benesch C, Sila C, Jovin T, Romano J: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316.

    2. *** CAPRIE Steering Committee: A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (caprie). Lancet 1996;348:1329-1339.

    3. *** Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.

    4. *** Costa J, Ferro JM, Matias-Guiu J, Alvarez-Sabin J, Torres F: Triflusal for preventing serious vascular events in people at high risk. Cochrane Database Syst Rev 2005:CD004296.

    5. *** Halkes P, van Gijn J, Kappelle L, Koudstaal P, Algra A: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (esprit): Randomised controlled trial. Lancet 2006;367:1665-1673.




    1. Chang YJ, Ryu SJ, Lee TH: Dose titration to reduce dipyridamole-related headache. Cerebrovasc Dis 2006;22:258-262.

    2. Diener H, Davidai G: Dipyridamole and headache. Future Neurology 2007;2:279-283.

    325 *** Diener H, Bogousslavsky J, Brass L, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht H: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (match): Randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-337.

    1. Yusuf S, Zhao F, Mehta S, Chrolavicius S, Tognoni G, Fox K, and the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndroms without st-segment elevation. N Engl J Med 2001;345:494-502.

    2. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP, Jr., Jackson CM, Pullicino P: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-1451.

    3. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group: A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997;42:857-865.

    329 *** Algra A: Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of
    arterial origin (esprit): A randomised controlled trial. Lancet Neurol 2007;6:115-124.

    1. EAFT (European Atrial Fibrillation Trial) Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.

    2. Visser CA, Kan G, Meltzer RS, Lie KI, Durrer D: Long-term follow-up of left ventricular thrombus after acute myocardial infarction. A two-dimensional echocardiographic study in 96 patients. Chest 1984;86:532-536.

    3. Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL: Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (sportif) trials. Am Heart J 2006;152:967-973.

    4. Dressler FA, Craig WR, Castello R, Labovitz AJ: Mobile aortic atheroma and systemic emboli: Efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998;31:134-138.

    5. Echiverri HC, Rubino FA, Gupta SR, Gujrati M: Fusiform aneurysm of the vertebrobasilar arterial system. Stroke 1989;20:1741-1747.

    6. Engelter ST, Brandt T, Debette S, Caso V, Lichy C, Pezzini A, Abboud S, Bersano A, Dittrich R, Grond-Ginsbach C, Hausser I, Kloss M, Grau AJ, Tatlisumak T, Leys D, Lyrer PA: Antiplatelets versus anticoagulation in cervical artery dissection. Stroke 2007;38:2605-2611.

    1. *** Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ: Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:107-116.

    2. *** European Carotid Surgery Trialists' Collaborative Group: Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the mrc european carotid surgery trial. Lancet 1996;347:1591-1593.

    3. *** Cina CS, Clase CM, Haynes RB: Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2000:CD001081.

    4. *** Rothwell P, Eliasziw M, Gutnikov S, Warlow C, HJM B, for the Carotid Endarterectomy Trialists Collaboration: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-924.




    1. Bond R, Rerkasem K, AbuRahma AF, Naylor AR, Rothwell PM: Patch angioplasty versus primary closure for carotid endarterectomy. Cochrane Database Syst Rev 2004:CD000160.

    2. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ: Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004;35:2855-2861.

    3. Inzitari D, Eliasziw M, Sharpe BL, Fox AJ, Barnett HJ: Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. North american symptomatic carotid endarterectomy trial group. Neurology 2000;54:660-666.

    4. Streifler JY, Eliasziw M, Benavente OR, Alamowitch S, Fox AJ, Hachinski VC, Barnett HJ: Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis. Stroke 2002;33:1651-1655.




    1. *** Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin J-P, Larrue V, Lièvre M, Leys D, Bonneville J-F, Watelet J, Pruvo J-P, Albucher J-F, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet J-C, Favrole P, Neau J-P, Ducrocq X, for the EVA-3S Investigators: Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. New England Journal of Medicine 2006;355:1660-1671.

    2. *** Ringleb PA, Allenberg JR, Berger J, Brückmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W: 30 day results from the space trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. Lancet 2006;368:1239-1247.

    346 Yadav J, Sholey M, Kuntz R, Fayad P, Katzen B, Mishkel G, Bajwa T, Whitlow P,
    Strickman N, Jaff M, Popma J, Snead D, Cutlip.D.E., Firth B, Ouriel K, for the Stenting and
    Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators: Protected
    carotid-artery stenting versus endarterectomy in high-risk patients. New England Journal of
    Medicine 2004;351:1493-1501.

    347 *** Cavatas Group: Endovascular versus surgical treatment in patients with carotid stenosis


    in the carotid and vertebral artery transluminal angioplasty study (cavatas): A randomised trial.
    Lancet 2001;357:1729-1737.

    1. Kastrup A, Groschel K: Carotid endarterectomy versus carotid stenting: An updated review of randomized trials and subgroup analyses. Acta Chir Belg 2007;107:119-128.

    2. The EC/IC Bypass Study Group: Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 1985;313:1191-1200.

    3. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-563.

    1. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N: Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis. Neurology 2007;68:856-858.

    2. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N: Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 2007;68:420-426.

    3. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, Do HM: Angioplasty for symptomatic intracranial stenosis: Clinical outcome. Stroke 2006;37:1016-1020.

    4. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG: Us multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke 2007;38:881-887.




    1. *** Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP: A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: The wingspan study. Stroke 2007;38:1531-1537.

    2. *** SSYLVIA Study investigators: Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (ssylvia): Study results. Stroke 2004;35:1388-1392.




    1. Lindstrom E, Boysen G, Christiansen L, Nansen B, Nielsen P: Reliability of scandinavian neurological stroke scale. Cerebrosvasc Dis 1991;1:103-107.

    2. Sulter G, Elting JW, Langedijk M, Maurits NM, De Keyser J: Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: A randomized pilot study. Stroke 2003;34:101-104.

    3. Cavallini A, Micieli G, Marcheselli S, Quaglini S: Role of monitoring in management of acute ischemic stroke patients. Stroke 2003;34:2599-2603.

    4. Ronning OM, Guldvog B: Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 1999;30:2033-2037.

    5. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C: The frequency, causes and timing of death within 30 days of a first stroke: The oxfordshire community stroke project. J Neurol Neurosurg Psychiatry 1990;53:824-829.

    6. Broderick JP, Phillips SJ, O'Fallon WM, Frye RL, Whisnant JP: Relationship of cardiac disease to stroke occurrence, recurrence, and mortality. Stroke 1992;23:1250-1256.

    7. Barber M, Morton JJ, Macfarlane PW, Barlow N, Roditi G, Stott DJ: Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis 2007;23:260-266.

    8. Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CD, Rudd AG: Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke 2000;31:2043-2048.

    9. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG: Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: The uk glucose insulin in stroke trial (gist-uk). Lancet Neurol 2007;6:397-406.

    10. Asplund K, Marke LA, Terent A, Gustafsson C, Wester P: Costs and gains in stroke prevention: European perspective. Cerebrosvasc Dis 1993;3 (suppl):34-42.

    11. Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A: Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35:520-526.

    12. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA: Blood pressure and clinical outcomes in the international stroke trial. Stroke 2002;33:1315-1320.

    13. Blood pressure in Acute Stroke Collaboration (BASC): Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2001:CD000039. Nazir FS, Overell JR, Bolster A, Hilditch TE, Lees KR: Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: A randomized controlled trial. Cerebrovasc Dis 2005;19:77-83.

    1. COSSACS investigators: Cossacs (continue or stop post-stroke antihypertensives collaborative study): Rationale and design. J Hypertens 2005;23:455-458.

    2. Thomas GN, Chan P, Tomlinson B: The role of angiotensin ii type 1 receptor antagonists in elderly patients with hypertension. Drugs Aging 2006;23:131-155.

    3. Grossman E, Messerli FH, Grodzicki T, Kowey P: Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996;276:1328-1331.

    4. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, Carlin J, Ratnaike S: Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry 1992;55:263-270.

    5. van Kooten F, Hoogerbrugge N, Naarding P, Koudstaal PJ: Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 1993;24:1129-1132.

    6. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-2214.

    7. Baird TA, Parsons MW, Barber PA, Butcher KS, Desmond PM, Tress BM, Colman PG, Jerums G, Chambers BR, Davis SM: The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci 2002;9:618-626.

    8. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM: Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52:20-28.

    9. Huff JS: Stroke mimics and chameleons. Emerg Med Clin North Am 2002;20:583-595.

    10. Fukuda H, Kitani M, Takahashi K: Body temperature correlates with functional outcome and the lesion size of cerebral infarction. Acta Neurol Scand 1999;100:385-390.

    11. Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS: Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996;347:422-425.

    12. Castillo J, Davalos A, Noya M: Aggravation of acute ischemic stroke by hyperthermia is related to an excitotoxic mechanism. Cerebrovasc Dis 1999;9:22-27.

    13. Hajat C, Hajat S, Sharma P: Effects of poststroke pyrexia on stroke outcome: A meta-analysis of studies in patients. Stroke 2000;31:410-414.

    14. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Scheider D, Diez-Tejedor E, Trouilas P: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ecass ii). Lancet 1998;352:1245-1251.

    15. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute stroke. JAMA 1995;274:1017-1025.




    1. *** Wardlaw JM, Zoppo G, Yamaguchi T, Berge E: Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003:CD000213.

    2. *** Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC, Jr., Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G: Association of outcome with early stroke treatment: Pooled analysis of atlantis, ecass, and ninds rt-pa stroke trials. Lancet 2004;363:768-774. Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR: Importance of early ischemic computed tomography changes using aspects in ninds rtpa stroke study. Stroke 2005;36:2110-2115.

    1. Sylaja PN, Cote R, Buchan AM, Hill MD: Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian alteplase for stroke effectiveness study. J Neurol Neurosurg Psychiatry 2006;77:826-829.

    2. van Oostenbrugge RJ, Hupperts RM, Lodder J: Thrombolysis for acute stroke with special emphasis on the very old: Experience from a single dutch centre. J Neurol Neurosurg Psychiatry 2006;77:375-377.

    3. Ringleb PA, Schwark C, Köhrmann M, Külkens S, Jüttler E, Hacke W, Schellinger PD: Thrombolytic therapy for acute ischaemic stroke in octogenarians: Selection by magnetic resonance imaging improves safety but does not improve outcome. J Neurol Neurosurg Psychiatry 2007;78:690-693.

    4. Elkind MS, Prabhakaran S, Pittman J, Koroshetz W, Jacoby M, Johnston KC: Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology 2007;68:842-848.

    5. Hill MD, Buchan AM: Thrombolysis for acute ischemic stroke: Results of the canadian alteplase for stroke effectiveness study (cases). CMAJ 2005;172:1307-1312.

    6. Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J: Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: An analysis of the nationwide inpatient sample 1999 to 2002. Stroke 2006;37:440-446.

    395 *** Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M,
    Külkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G: Thrombolysis with
    alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-
    monitoring study (sits-most): An observational study. Lancet 2007;369:275-282.

    1. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM: Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: A cleveland update. Stroke 2003;34:799-800.

    2. Graham GD: Tissue plasminogen activator for acute ischemic stroke in clinical practice: A meta-analysis of safety data. Stroke 2003;34:2847-2850.

    3. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moye LA, Hill MD, Wojner AW: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-2178.

    4. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, Arenillas JF, Huertas R, Purroy F, Delgado P, Alvarez-Sabin J: Microbubble administration accelerates clot lysis during continuous 2-mhz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006;37:425-429.

    5. Köhrmann M, Jüttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, Ringleb PA, Schellinger PD, Hacke W: Mri versus ct-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: A cohort study. Lancet Neurol 2006;5:661-667.

    6. Schellinger PD, Thomalla G, Fiehler J, Kohrmann M, Molina CA, Neumann-Haefelin T, Ribo M, Singer OC, Zaro-Weber O, Sobesky J: Mri-based and ct-based thrombolytic therapy in acute stroke within and beyond established time windows: An analysis of 1210 patients. Stroke 2007;38:2640-2645.

    402 *** Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman CA, Marks MP, Albers GW: Risk
    factors of symptomatic intracerebral hemorrhage after tpa therapy for acute stroke. Stroke
    2007;38:2275-2278.

    403 The Multicenter Acute Stroke Trial - Europe Study Group: Thrombolytic therapy with


    streptokinase in acute ischemic stroke. N Engl Jl Med 1996;335:145-150. (MAST-I) Group: Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre acute stroke trial-italy. Lancet 1995;346:1509-1514.

    1. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S: The desmoteplase in acute ischemic stroke trial (dias): A phase ii mri-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.

    2. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W: Dose escalation of desmoteplase for acute ischemic stroke (dedas): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-1231.

    3. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T: Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: The middle cerebral artery embolism local fibrinolytic intervention trial (melt) japan. Stroke 2007;38:2633-2639.

    4. Nedeltchev K, Fischer U, Arnold M, Ballinari P, Haefeli T, Kappeler L, Brekenfeld C, Remonda L, Schroth G, Mattle HP: Long-term effect of intra-arterial thrombolysis in stroke. Stroke 2006;37:3002-3007.

    5. IMS investigators: The interventional management of stroke (ims) ii study. Stroke 2007;38:2127-2135.

    6. Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, Stewart-Wynne EG, Rosen D, McNeil JJ, Bladin CF, Chambers BR, Herkes GK, Young D, Donnan GA: Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005;20:12-17.

    7. Brandt T, von Kummer R, Muller Kuppers M, Hacke W: Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996;27:875-881.

    8. Hacke W, Zeumer H, Ferbert A, Brückmann H, DelZoppo G: Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216-1222.




    1. *** Lindsberg PJ, Mattle HP: Therapy of basilar artery occlusion: A systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006;37:922-928.

    2. *** Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the merci trial. Stroke 2005;36:1432-1438.

    3. *** International-Stroke-Trial-Collaborative-Group: The international stroke trial (ist): A randomised trial if aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997;349:1569-1581.

    4. *** CAST-Collaborative-Group: Cast:Randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischeaemic stroke. Lancet 1997;349:1641-1649.

    417 Rödén-Jüllig A, Britton M, Malmkvist K, Leijd B: Aspirin in the prevention of progressing
    stroke: A randomized controlled study. J Intern Med 2003;254:584-590.

    1. *** AbESST investigators: Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of a randomized phase 2 trial. Stroke 2005;36:880-890.

    2. *** Adams HP, Jr., Effron MB, Torner J, Davalos A, Frayne J, Teal P, Leclerc J, Oemar B, Padgett L, Barnathan ES, Hacke W: Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of an international phase iii trial. Abciximab in emergency treatment of stroke trial (abestt-ii). Stroke 2008;39:87-99.

    3. *** Kay R, Wong KS, Yu YL, Chan YW, Tsoi TH, Ahuja AT, Chan FL, Fong KY, Law CB, Wong A: Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-1593.

    4. *** Wong KS, Chen C, Ng PW, Tsoi TH, Li HL, Fong WC, Yeung J, Wong CK, Yip KK, Gao H, Wong HB: Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in asian patients with large artery occlusive disease: A randomised study. Lancet Neurol 2007;6:407-413.

    1. *** Diener HC, Ringelstein EB, von Kummer R, Langohr HD, Bewermeyer H, Landgraf H, Hennerici M, Welzel D, Grave M, Brom J, Weidinger G: Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: Results of the topas trial. Therapy of patients with acute stroke (topas) investigators. Stroke 2001;32:22-29.

    2. *** Bath PM, Lindenstrom E, Boysen G, De Deyn P, Friis P, Leys D, Marttila R, Olsson J, O'Neill D, Orgogozo J, Ringelstein B, van der Sande J, Turpie AG: Tinzaparin in acute ischaemic stroke (taist): A randomised aspirin-controlled trial. Lancet 2001;358:702-710.

    3. *** Berge E, Abdelnoor M, Nakstad PH, Sandset PM: Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study. Haest study group. Heparin in acute embolic stroke trial. Lancet 2000;355:1205-1210.

    4. *** The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators: Low molecular weight heparinoid, org 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial. JAMA 1998;279:1265-1272.

    5. *** Gubitz G, Sandercock P, Counsell C: Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004:CD000024.




    1. Camerlingo M, Salvi P, Belloni G, Gamba T, Cesana BM, Mamoli A: Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke 2005;36:2415-2420.

    2. Chamorro A, Busse O, Obach V, Toni D, Sandercock P, Reverter JC, Cervera A, Torres F, Davalos A: The rapid anticoagulation prevents ischemic damage study in acute stroke--final results from the writing committee. Cerebrovasc Dis 2005;19:402-404.

    3. Chamorro A: Immediate anticoagulation for acute stroke in atrial fibrillation: Yes. Stroke 2006;37:3052-3053.

    4. Sandercock P: Immediate anticoagulation for acute stroke in atrial fibrillation: No. Stroke 2006;37:3054-3055.




    1. *** Paciaroni M, Agnelli G, Micheli S, Caso V: Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: A meta-analysis of randomized controlled trials. Stroke 2007;38:423-430.

    2. *** Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U: Nxy-059 for the treatment of acute ischemic stroke. N Engl J Med 2007;357:562-571.

    3. *** Muir KW, Lees KR, Ford I, Davis S: Magnesium for acute stroke (intravenous magnesium efficacy in stroke trial): Randomised controlled trial. Lancet 2004;363:439-445.




    1. Amaro S, Soy D, Obach V, Cervera A, Planas AM, Chamorro A: A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke. Stroke 2007;38:2173-2175.

    2. Davalos A, Castillo J, Alvarez-Sabin J, Secades JJ, Mercadal J, Lopez S, Cobo E, Warach S, Sherman D, Clark WM, Lozano R: Oral citicoline in acute ischemic stroke: An individual patient data pooling analysis of clinical trials. Stroke 2002;33:2850-2857.

    3. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R: 'malignant' middle cerebral artery territory infarction: Clinical course and prognostic signs. Arch Neurol 1996;53:309-315.

    4. Qureshi AI, Suarez JI, Yahia AM, Mohammad Y, Uzun G, Suri MF, Zaidat OO, Ayata C, Ali Z, Wityk RJ: Timing of neurologic deterioration in massive middle cerebral artery infarction: A multicenter review. Crit Care Med 2003;31:272-277. Unterberg AW, Kiening KL, Hartl R, Bardt T, Sarrafzadeh AS, Lanksch WR: Multimodal monitoring in patients with head injury: Evaluation of the effects of treatment on cerebral oxygenation. J Trauma 1997;42:S32-37.

    1. Righetti E, Celani MG, Cantisani TA, Sterzi R, Boysen G, Ricci S: Glycerol for acute stroke: A cochrane systematic review. J Neurol 2002;249:445-451.

    2. Bereczki D, Liu M, do Prado GF, Fekete I: Mannitol for acute stroke. Cochrane Database Syst Rev 2001;1:CD001153.

    3. Schwarz S, Georgiadis D, Aschoff A, Schwab S: Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002;33:136-140.

    442 *** Qizilbash N, Lewington SL, Lopez-Arrieta JM: Corticosteroids for acute ischaemic stroke.
    Cochrane Database Syst Rev 2002;2:CD000064

    1. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W: Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998;29:2461-2466.

    2. Steiner T, Ringleb P, Hacke W: Treatment options for large hemispheric stroke. Neurology 2001;57(5 Suppl 2):S61-68.

    3. Els T, Oehm E, Voigt S, Klisch J, Hetzel A, Kassubek J: Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke. Cerebrovasc Dis 2006;21:79-85.

    4. Vahedi K, Hofmeijer J, Jüttler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W: Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6:215-222.

    5. Juttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W: Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (destiny): A randomized, controlled trial. Stroke 2007;38:2518-2525.

    6. Gupta R, Connolly ES, Mayer S, Elkind MS: Hemicraniectomy for massive middle cerebral artery territory infarction: A systematic review. Stroke 2004;35:539-543.

    7. Weimar C, Roth MP, Zillessen G, Glahn J, Wimmer ML, Busse O, Haberl RL, Diener HC: Complications following acute ischemic stroke. Eur Neurol 2002;48:133-140.

    8. Horner J, Massey EW, Riski JE, Lathrop DL, Chase KN: Aspiration following stroke: Clinical correlates and outcome. Neurology 1988;38:1359-1362.

    9. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke t helper cell type 1-like immunostimulation. J Exp Med 2003;198:725-736.

    10. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Torres F, Planas AM: Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry 2006;77:1279-1281.

    11. Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, Torres F, Cervera A, Planas AM, Mensa J: The early systemic prophylaxis of infection after stroke study: A randomized clinical trial. Stroke 2005;36:1495-1500.

    454 *** Mazzone C, Chiodo GF, Sandercock P, Miccio M, Salvi R: Physical methods for
    preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 2004:CD001922.

    455 Kamphuisen PW, Agnelli G, Sebastianelli M: Prevention of venous thromboembolism after


    acute ischemic stroke. J Thromb Haemost 2005;3:1187-1194.

    456 *** Diener HC, Ringelstein EB, von Kummer R, Landgraf H, Koppenhagen K, Harenberg J,


    Rektor I, Csanyi A, Schneider D, Klingelhofer J, Brom J, Weidinger G: Prophylaxis of thrombotic

    and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: Results of the protect trial. Stroke 2006;37:139-144.



    457 *** Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo
    GF: The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of
    venous thromboembolism after acute ischaemic stroke (prevail study): An open-label randomised
    comparison. Lancet 2007;369:1347-1355.

    1. Reddy M, Gill SS, Rochon PA: Preventing pressure ulcers: A systematic review. JAMA 2006;296:974-984.

    2. Forster A, Young J: Incidence and consequences of falls due to stroke: A systematic inquiry. BMJ 1995;311:83-86.

    3. Mackintosh SF, Goldie P, Hill K: Falls incidence and factors associated with falling in older, community-dwelling, chronic stroke survivors (> 1 year after stroke) and matched controls. Aging Clin Exp Res 2005;17:74-81.

    4. Mackintosh SF, Hill KD, Dodd KJ, Goldie PA, Culham EG: Balance score and a history of falls in hospital predict recurrent falls in the 6 months following stroke rehabilitation. Arch Phys Med Rehabil 2006;87:1583-1589.

    5. Lamb SE, Ferrucci L, Volapto S, Fried LP, Guralnik JM: Risk factors for falling in home-dwelling older women with stroke: The women's health and aging study. Stroke 2003;34:494-501.

    6. Aizen E, Shugaev I, Lenger R: Risk factors and characteristics of falls during inpatient rehabilitation of elderly patients. Arch Gerontol Geriatr 2007;44:1-12.

    7. Teasell R, McRae M, Foley N, Bhardwaj A: The incidence and consequences of falls in stroke patients during inpatient rehabilitation: Factors associated with high risk. Arch Phys Med Rehabil 2002;83:329-333.

    8. Vassallo M, Vignaraja R, Sharma JC, Hallam H, Binns K, Briggs R, Ross I, Allen S: The effect of changing practice on fall prevention in a rehabilitative hospital: The hospital injury prevention study. J Am Geriatr Soc 2004;52:335-339.

    9. Oliver D, Connelly JB, Victor CR, Shaw FE, Whitehead A, Genc Y, Vanoli A, Martin FC, Gosney MA: Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: Systematic review and meta-analyses. BMJ 2007;334:82.

    10. Ramnemark A, Nyberg L, Borssen B, Olsson T, Gustafson Y: Fractures after stroke. Osteoporos Int 1998;8:92-95.

    11. Ramnemark A, Nilsson M, Borssen B, Gustafson Y: Stroke, a major and increasing risk factor for femoral neck fracture. Stroke 2000;31:1572-1577.

    469 *** Pang MY, Eng JJ, Dawson AS, Gylfadottir S: The use of aerobic exercise training in
    improving aerobic capacity in individuals with stroke: A meta-analysis. Clin Rehabil 2006;20:97-
    111.

    1. Sato Y, Iwamoto J, Kanoko T, Satoh K: Low-dose vitamin d prevents muscular atrophy and reduces falls and hip fractures in women after stroke: A randomized controlled trial. Cerebrovasc Dis 2005;20:187-192.

    2. Sato Y, Asoh T, Kaji M, Oizumi K: Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke. J Bone Miner Res 2000;15:2487-2494.

    3. Parker MJ, Gillespie LD, Gillespie WJ: Hip protectors for preventing hip fractures in the elderly. Cochrane Database Syst Rev 2001:CD001255.

    4. Gerberding JL: Hospital-onset infections: A patient safety issue. Ann Intern Med 2002;137:665-670.

    5. Jorgensen L, Engstad T, Jacobsen BK: Self-reported urinary incontinence in noninstitutionalized long-term stroke survivors: A population-based study. Arch Phys Med Rehabil 2005;86:416-420. Thomas LH, Barrett J, Cross S, French B, Leathley M, Sutton C, Watkins C: Prevention and treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2005:CD004462.

    1. Meijer R, Ihnenfeldt DS, de Groot IJ, van Limbeek J, Vermeulen M, de Haan RJ: Prognostic factors for ambulation and activities of daily living in the subacute phase after stroke. A systematic review of the literature. Clin Rehabil 2003;17:119-129.

    2. Thomas LH, Cross S, Barrett J, French B, Leathley M, Sutton CJ, Watkins C: Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2008:CD004462.

    3. Dumoulin C, Korner-Bitensky N, Tannenbaum C: Urinary incontinence after stroke: Does rehabilitation make a difference? A systematic review of the effectiveness of behavioral therapy. Top Stroke Rehabil 2005;12:66-76.

    4. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R: Dysphagia after stroke: Incidence, diagnosis, and pulmonary complications. Stroke 2005;36:2756-2763.

    5. Mann G, Hankey GJ, Cameron D: Swallowing function after stroke: Prognosis and prognostic factors at 6 months. Stroke 1999;30:744-748.

    6. Dennis MS, Lewis SC, Warlow C: Routine oral nutritional supplementation for stroke patients in hospital (food): A multicentre randomised controlled trial. Lancet 2005;365:755-763.

    7. Axelsson K, Asplund K, Norberg A, Alafuzoff I: Nutritional status in patients with acute stroke. Acta Med Scand 1988;224:217-224.

    8. Axelsson K, Asplund K, Norberg A, Eriksson S: Eating problems and nutritional status during hospital stay of patients with severe stroke. J Am Diet Assoc 1989;89:1092-1096.

    9. Finestone HM, Greene-Finestone LS, Wilson ES, Teasell RW: Malnutrition in stroke patients on the rehabilitation service and at follow-up: Prevalence and predictors. Arch Phys Med Rehabil 1995;76:310-316.

    10. Finestone HM, Greene-Finestone LS, Wilson ES, Teasell RW: Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehabil 1996;77:340-345.

    11. Dávalos A, Ricart W, Gonzalez-Huix F, Soler S, Marrugat J, Molins A, Suner R, Genis D: Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996;27:1028-1032.

    12. Food trial collaboration: Poor nutritional status on admission predicts poor outcomes after stroke: Observational data from the food trial. Stroke 2003;34:1450-1456.

    488 *** Dennis MS, Lewis SC, Warlow C: Effect of timing and method of enteral tube feeding for
    dysphagic stroke patients (food): A multicentre randomised controlled trial. Lancet 2005;365:764-
    772.

    1. Norton B, Homer-Ward M, Donnelly MT, Long RG, Holmes GK: A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ 1996;312:13-16.

    2. Hamidon BB, Abdullah SA, Zawawi MF, Sukumar N, Aminuddin A, Raymond AA: A prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with acute dysphagic stroke. Med J Malaysia 2006;61:59-66.

    3. Callahan CM, Haag KM, Weinberger M, Tierney WM, Buchanan NN, Stump TE, Nisi R: Outcomes of percutaneous endoscopic gastrostomy among older adults in a community setting. J Am Geriatr Soc 2000;48:1048-1054.

    4. Rickman J: Percutaneous endoscopic gastrostomy: Psychological effects. Br J Nurs 1998;7:723-729.

    5. WHO: International classification of functioning disability and health: Geneva World Health Organisation, 2001,

    1. Langhorne P, Dennis MS: Stroke units, an evidence based approach. London, BMJ Publishing group, 1998.

    2. Lincoln NB, Husbands S, Trescoli C, Drummond AE, Gladman JR, Berman P: Five year follow up of a randomised controlled trial of a stroke rehabilitation unit. BMJ 2000;320:549.

    3. Indredavik B, Slordahl SA, Bakke F, Rokseth R, Haheim LL: Stroke unit treatment. Long-term effects. Stroke 1997;28:1861-1866.

    4. Early Supported Discharge Trialists: Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev 2005:CD000443.

    5. Langhorne P, Taylor G, Murray G, Dennis M, Anderson C, Bautz-Holter E, Dey P, Indredavik B, Mayo N, Power M, Rodgers H, Ronning OM, Rudd A, Suwanwela N, Widen-Holmqvist L, Wolfe C: Early supported discharge services for stroke patients: A meta-analysis of individual patients' data. Lancet 2005;365:501-506.

    6. Ronning OM, Guldvog B: Outcome of subacute stroke rehabilitation: A randomized controlled trial. Stroke 1998;29:779-784.

    500 *** Legg L, Langhorne P: Rehabilitation therapy services for stroke patients living at home:
    Systematic review of randomised trials. Lancet 2004;363:352-356.

    1. Baron JC, Cohen LG, Cramer SC, Dobkin BH, Johansen-Berg H, Loubinoux I, Marshall RS, Ward NS: Neuroimaging in stroke recovery: A position paper from the first international workshop on neuroimaging and stroke recovery. Cerebrovasc Dis 2004;18:260-267.

    2. Barbay S, Plautz E, Friel K, Frost F, Stowe A, Dancause N, Wang H, Nudo R: Delayed rehabilitative training following a small ischaemic infarct in non-human primate primary cortex. Soc Neurosci abstr 2001;27:931-934.

    3. Biernaskie J, Chernenko G, Corbett D: Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci 2004;24:1245-1254.

    4. Paolucci S, Antonucci G, Grasso MG, Morelli D, Troisi E, Coiro P, Bragoni M: Early versus delayed inpatient stroke rehabilitation: A matched comparison conducted in italy. Arch Phys Med Rehabil 2000;81:695-700.

    5. Salter K, Jutai J, Hartley M, Foley N, Bhogal S, Bayona N, Teasell R: Impact of early vs delayed admission to rehabilitation on functional outcomes in persons with stroke. J Rehabil Med 2006;38:113-117.

    6. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G: Medical complications after stroke: A multicenter study. Stroke 2000;31:1223-1229.

    7. Diserens K, Michel P, Bogousslavsky J: Early mobilisation after stroke: Review of the literature. Cerebrovasc Dis 2006;22:183-190.

    8. Bernhardt J, Dewey H, Thrift A, Donnan G: Inactive and alone: Physical activity within the first 14 days of acute stroke unit care. Stroke 2004;35:1005-1009.




    1. *** Aziz N, Leonardi-Bee J, Walker M, Phillips M, Gladman J, Legg L: Therapy-based rehabilitation services for patients living at home more than one year after stroke. Cochrane Database Syst Rev 2008;2:CD005952.

    2. *** Kwakkel G, van Peppen R, Wagenaar RC, Wood Dauphinee S, Richards C, Ashburn A, Miller K, Lincoln N, Partridge C, Wellwood I, Langhorne P: Effects of augmented exercise therapy time after stroke: A meta-analysis. Stroke 2004;35:2529-2539.

    3. *** Langhorne P, Wagenaar R, Partridge C: Physiotherapy after stroke: More is better? Physiother Res Int 1996;1:75-88.

    4. *** van der Lee JH, Snels IA, Beckerman H, Lankhorst GJ, Wagenaar RC, Bouter LM: Exercise therapy for arm function in stroke patients: A systematic review of randomized controlled trials. Clin Rehabil 2001;15:20-31.

    1. Evans A, Perez I, Harraf F, Melbourn A, Steadman J, Donaldson N, Kalra L: Can differences in management processes explain different outcomes between stroke unit and stroke-team care? Lancet 2001;358:1586-1592.

    2. Kalra L, Dale P, Crome P: Improving stroke rehabilitation. A controlled study. Stroke 1993;24:1462-1467.

    3. Stroke Unit Trialists' Collaboration: How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke unit trialists collaboration. Stroke 1997;28:2139-2144.




    1. *** van Peppen RP, Kwakkel G, Wood-Dauphinee S, Hendriks HJ, Van der Wees PJ, Dekker J: The impact of physical therapy on functional outcomes after stroke: What's the evidence? Clin Rehabil 2004;18:833-862.

    2. *** Pollock A, Baer G, Langhorne P, Pomeroy V: Physiotherapy treatment approaches for the recovery of postural control and lower limb function following stroke: A systematic review. Clin Rehabil 2007;21:395-410.

    3. *** Pomeroy VM, King LM, Pollock A, Baily-Hallam A, Langhorne P: Electrostimulation for promoting recovery of movement or functional ability after stroke. Systematic review and meta-analysis. Stroke 2006;37:2441 - 2442.

    4. *** Moseley AM, Stark A, Cameron ID, Pollock A: Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev 2005:CD002840.




    1. Mehrholz J, Werner C, Kugler J, Pohl M: Electromechanical-assisted training for walking after stroke. Cochrane Database Syst Rev 2007:CD006185.

    2. de Wit DC, Buurke JH, Nijlant JM, Ijzerman MJ, Hermens HJ: The effect of an ankle-foot orthosis on walking ability in chronic stroke patients: A randomized controlled trial. Clin Rehabil 2004;18:550-557.

    3. Gordon NF, Gulanick M, Costa F, Fletcher G, Franklin BA, Roth EJ, Shephard T: Physical activity and exercise recommendations for stroke survivors: An american heart association scientific statement from the council on clinical cardiology, subcommittee on exercise, cardiac rehabilitation, and prevention; the council on cardiovascular nursing; the council on nutrition, physical activity, and metabolism; and the stroke council. Stroke 2004;35:1230-1240.

    4. Wolf SL, Winstein CJ, Miller JP, Taub E, Uswatte G, Morris D, Giuliani C, Light KE, Nichols-Larsen D: Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: The excite randomized clinical trial. JAMA 2006;296:2095-2104.




    1. *** Legg LA, Drummond AE, Langhorne P: Occupational therapy for patients with problems in activities of daily living after stroke. Cochrane Database Syst Rev 2006:CD003585.

    2. *** Walker M, Leonardi-Bee J, Bath P, Langhorn P, Dewey M, Corr S, Drummond A, Gilbertson L, Gladman J, Jongbloed L, Logan P, Parker C: Individual patient data meta-analysis of randomised controlled trials of community occupational therapy for stroke patients. Stroke 2004;35:2226-2232.




    1. Sackley C, Wade DT, Mant D, Atkinson JC, Yudkin P, Cardoso K, Levin S, Lee VB, Reel K: Cluster randomized pilot controlled trial of an occupational therapy intervention for residents with stroke in uk care homes. Stroke 2006;37:2336-2341.

    2. Bath PM, Bath FJ, Smithard DG: Interventions for dysphagia in acute stroke. Cochrane Database Syst Rev 2000:CD000323.

    3. DePippo KL, Holas MA, Reding MJ, Mandel FS, Lesser ML: Dysphagia therapy following stroke: A controlled trial. Neurology 1994;44:1655-1660.

    4. Engelter ST, Gostynski M, Papa S, Frei M, Born C, Ajdacic-Gross V, Gutzwiller F, Lyrer PA: Epidemiology of aphasia attributable to first ischemic stroke: Incidence, severity, fluency, etiology, and thrombolysis. Stroke 2006;37:1379-1384.

    1. *** Sellars C, Hughes T, Langhorne P: Speech and language therapy for dysarthria due to non-progressive brain damage. Cochrane Database Syst Rev 2005:CD002088.

    2. *** Greener J, Enderby P, Whurr R: Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2000:CD000425.




    1. Robey RR: The efficacy of treatment for aphasic persons: A meta-analysis. Brain Lang 1994;47:582-608.

    2. Robey RR: A meta-analysis of clinical outcomes in the treatment of aphasia. J Speech Lang Hear Res 1998;41:172-187.

    3. Pulvermuller F, Neininger B, Elbert T, Mohr B, Rockstroh B, Koebbel P, Taub E: Constraint-induced therapy of chronic aphasia after stroke. Stroke 2001;32:1621-1626.

    4. Bhogal SK, Teasell R, Speechley M: Intensity of aphasia therapy, impact on recovery. Stroke 2003;34:987-993.

    536 *** Stroke Liaison Workers Collaboration: Meta-analysis of stroke liaison workers for patients
    and carers: Results by intervention characteristic. Cerebrovasc Dis 2006;21:120.

    537 O'Mahony PG, Rodgers H, Thomson RG, Dobson R, James OF: Satisfaction with


    information and advice received by stroke patients. Clin Rehabil 1997;11:68-72.

    538 *** Forster A, Young J, Langhorne P: Medical day hospital care for the elderly versus


    alternative forms of care. Cochrane Database Syst Rev 2000:CD001730.

    1. Kalra L, Evans A, Perez I, Melbourn A, Patel A, Knapp M, Donaldson N: Training carers of stroke patients: Randomised controlled trial. BMJ 2004;328:1099.

    2. Johansson BB: Brain plasticity and stroke rehabilitation. The willis lecture. Stroke 2000;31:223-230.

    3. Nair RD, Lincoln NB: Cognitive rehabilitation for memory deficits following stroke. Cochrane Database Syst Rev 2007:CD002293.

    4. Lincoln NB, Majid MJ, Weyman N: Cognitive rehabilitation for attention deficits following stroke. Cochrane Database Syst Rev 2000:CD002842.

    5. Bowen A, Lincoln NB: Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database Syst Rev 2007:CD003586.

    6. Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, Ellmo W, Kalmar K, Giacino JT, Harley JP, Laatsch L, Morse PA, Catanese J: Evidence-based cognitive rehabilitation: Updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005;86:1681-1692.

    7. Marinkovic S, Badlani G: Voiding and sexual dysfunction after cerebrovascular accidents. J Urol 2001;165:359-370.

    8. Sjogren K, Fugl-Meyer AR: Adjustment to life after stroke with special reference to sexual intercourse and leisure. J Psychosom Res 1982;26:409-417.

    9. Muller JE: Triggering of cardiac events by sexual activity: Findings from a case-crossover analysis. Am J Cardiol 2000;86:14F-18F.

    10. McLean DE: Medical complications experienced by a cohort of stroke survivors during inpatient, tertiary-level stroke rehabilitation. Arch Phys Med Rehabil 2004;85:466-469.

    11. Paolucci S, Antonucci G, Pratesi L, Traballesi M, Lubich S, Grasso MG: Functional outcome in stroke inpatient rehabilitation: Predicting no, low and high response patients. Cerebrovasc Dis 1998;8:228-234.

    12. Hackett ML, Anderson CS: Predictors of depression after stroke: A systematic review of observational studies. Stroke 2005;36:2296-2301.

    13. Paolucci S, Gandolfo C, Provinciali L, Torta R, Toso V: The italian multicenter observational study on post-stroke depression (destro). J Neurol 2006;253:556-562.

    1. Linden T, Blomstrand C, Skoog I: Depressive disorders after 20 months in elderly stroke patients: A case-control study. Stroke 2007;38:1860-1863.

    2. Thomas SA, Lincoln NB: Factors relating to depression after stroke. Br J Clin Psychol 2006;45:49-61.

    3. Kauhanen M, Korpelainen JT, Hiltunen P, Brusin E, Mononen H, Maatta R, Nieminen P, Sotaniemi KA, Myllyla VV: Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 1999;30:1875-1880.




    1. *** van de Meent H, Geurts AC, Van Limbeek J: Pharmacologic treatment of poststroke depression: A systematic review of the literature. Top Stroke Rehabil 2003;10:79-92.

    2. *** Hackett ML, Anderson CS, House AO: Management of depression after stroke: A systematic review of pharmacological therapies. Stroke 2005;36:1098-1103.

    3. *** Bhogal SK, Teasell R, Foley N, Speechley M: Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. J Am Geriatr Soc 2005;53:1051-1057.

    4. *** Anderson CS, Hackett ML, House AO: Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2004:CD003689.

    5. *** House AO, Hackett ML, Anderson CS, Horrocks JA: Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev 2004:CD003690.




    1. Lindgren I, Jonsson AC, Norrving B, Lindgren A: Shoulder pain after stroke: A prospective population-based study. Stroke 2007;38:343-348.

    2. Vuagnat H, Chantraine A: Shoulder pain in hemiplegia revisited: Contribution of functional electrical stimulation and other therapies. J Rehabil Med 2003;35:49-54.

    562 *** Price CI, Pandyan AD: Electrical stimulation for preventing and treating post-stroke
    shoulder pain: A systematic cochrane review. Clin Rehabil 2001;15:5-19.

    563 Ada L, Foongchomcheay A, Canning C: Supportive devices for preventing and treating


    subluxation of the shoulder after stroke. Cochrane Database Syst Rev 2005:CD003863.

    1. *** Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A: Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005:CD001133.

    2. *** Satkunam LE: Rehabilitation medicine: 3. Management of adult spasticity. CMAJ 2003;169:1173-1179.




    1. Lannin NA, Herbert RD: Is hand splinting effective for adults following stroke? A systematic review and methodologic critique of published research. Clin Rehabil 2003;17:807-816.

    2. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C: Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400.

    3. van Kuijk AA, Geurts AC, Bevaart BJ, van Limbeek J: Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: A systematic review of the literature. J Rehabil Med 2002;34:51-61.

    4. Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovsky P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E: A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type a (dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 2003;15:289-300.

    5. Meythaler JM, Guin-Renfroe S, Johnson A, Brunner RM: Prospective assessment of tizanidine for spasticity due to acquired brain injury. Arch Phys Med Rehabil 2001;82:1155-1163.

    6. Shah S, Vanclay F, Cooper B: Efficiency, effectiveness, and duration of stroke rehabilitation. Stroke 1990;21:241-246.

    1. Wyller TB, Sodring KM, Sveen U, Ljunggren AE, Bautz-Holter E: Are there gender differences in functional outcome after stroke? Clin Rehabil 1997;11:171-179.

    2. Chae J, Zorowitz RD, Johnston MV: Functional outcome of hemorrhagic and nonhemorrhagic stroke patients after in-patient rehabilitation. Am J Phys Med Rehabil 1996;75:177-182.

    3. Falconer JA, Naughton BJ, Strasser DC, Sinacore JM: Stroke inpatient rehabilitation: A comparison across age groups. J Am Geriatr Soc 1994;42:39-44.

    4. Katz N, Hartman-Maeir A, Ring H, Soroker N: Functional disability and rehabilitation outcome in right hemisphere damaged patients with and without unilateral spatial neglect. Arch Phys Med Rehabil 1999;80:379-384.

    5. Ween JE, Alexander MP, D'Esposito M, Roberts M: Factors predictive of stroke outcome in a rehabilitation setting. Neurology 1996;47:388-392.

    6. Gladman JR, Sackley CM: The scope for rehabilitation in severely disabled stroke patients. Disabil Rehabil 1998;20:391-394.

    7. Rodgers H: The scope for rehabilitation in severely disabled stroke patients. Disabil Rehabil 2000;22:199-200.

    8. van Peppen RP, Hendriks HJ, van Meeteren NL, Helders PJ, Kwakkel G: The development of a clinical practice stroke guideline for physiotherapists in the netherlands: A systematic review of available evidence. Disabil Rehabil 2007;29:767-783.

    9. Kalra L, Eade J: Role of stroke rehabilitation units in managing severe disability after stroke. Stroke 1995;26:2031-2034.

    10. Schmidt J, Drew-Cates J, Dombovy M: Severe disability after stroke: Outcome after inpatient rehabilitation. Neurorehab Neural Repair 1999;13:199-203.

    11. Brainin M, Barnes M, Baron JC, Gilhus NE, Hughes R, Selmaj K, Waldemar G: Guidance for the preparation of neurological management guidelines by efns scientific task forces--revised recommendations 2004. Eur J Neurol 2004;11:577-581.

    12. Hankey GJ, Warlow CP: Treatment and secondary prevention of stroke: Evidence, costs, and effects on individuals and populations. Lancet 1999;354:1457-1463.

    13. Ringleb PA, Hacke W: [stent and surgery for symptomatic carotid stenosis. Space study results]. Nervenarzt 2007;78:1130-1137.

    Список литературы,

    использованной при адаптации клинических рекомендаций


    1. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011; 42:227

    2. Sacks FM, Campos H. Dietary therapy in hypertension. N Engl J Med 2010; 362:2102

    3. Волошин В.П. История, современный уровень и будущее тромболитической терапии при остром ишемическом инсульте / В.П.Волошин, В.А.Яворська, Ю.В.Фломін // Укр. мед. часопис.- 2007. - №5 (61) –ІХ/Х. – с.9-23.

    4. Зозуля І.С., Мошенська О.П. Гострий період ішемічного інсульту: сучасний погляд на проблему// Укр. мед. часопис.- 2009. - №4 (72) – VII/VIII. – с. 67-73.

    5. Зозуля І.С. Епідеміологія цереброваскулярних захворювань в Україні / І.С.Зозуля, А.І.Зозуля // Український медичний часопис. – 2011. - №5(85). – ІХ-Х. – с. 38-41.

    6. Прихода И.В., Подорожко О.А. Вторичная профилактика ишемического инсульта и транзиторной ишемической атаки//Ремендиум. Жирнал о рынке лекарств и медицинской техники. – 2006р- 7.- С. 18-23

    7. Наказ МОЗ України від 30.07.2002р №297 «Про вдосконалення медичної допомоги хворим з цереброваскулярною патологією»;

    8. Наказ МОЗ України від 17.01.2005р №24 «Про затвердження протоколів надання медичної допомоги за спеціальністю "Медицина невідкладних станів"»

    9. Наказом МОЗ України від 03.07.2006р №436 «Про затвердження протоколів надання медичної допомоги за спеціальністю „Кардіологія"»

    10. Наказ МОЗ України від 17.08.2007р №487 «Про затвердження клінічних протоколів надання медичної допомоги за спеціальністю „Неврологія"»

    11. Наказ МОЗ України від 13.06.2008р №317 «Про затвердження клінічних протоколів надання медичної допомоги за спеціальністю „Нейрохірургія"»

    12. NICE clinical guideline 68.Stroke: diagnosis and initial management of acute stroke and transient ischaemic attack (TIA).

    13. LIPID MODIFICATION: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease, NICE, 2008;

    14. Lipid Management in Adults, Institute for Clinical Systems Improvement, 2011



    ДОПОЛНЕНИЯ

    Коментар робочої групи:

    Алгоритми надання медичної допомоги пацієнтам з підозрою на ішемічний інсульт та ТІА. [NICE clinical guideline 68. Stroke: diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)]







    • 1   2   3   4   5   6   7   8   9   10   11

    Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
    rəhbərliyinə müraciət